The predicted change of expression is in agreement with Pancan data on breast cancer patients that show the alternative allele of this variant to be associated with higher expression levels of CHPT1 gene (source: PancanQTL53, beta = 0.17; see Supplementary Fig. 7). This evidence concerns the gene CHPT1 and breast carcinoma.